| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.43 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.32 | 0.07 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.31 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-05 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.18 | 0.6 |